▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁is 5.5546875
▁still 6.25390625
▁considered 5.03125
▁to 1.7314453125
▁be 0.4521484375
▁an 3.0078125
▁extreme 5.94921875
▁issue 7.3828125
▁among 7.328125
▁at 6.82421875
▁least 1.4091796875
▁ 2.65234375
8 3.197265625
% 4.31640625
▁of 1.8486328125
▁the 1.236328125
▁residents 6.89453125
▁of 2.294921875
▁progress 9.4140625
ive 0.9912109375
▁countries 6.890625
. 2.107421875
▁The 2.505859375
▁introduction 7.234375
▁of 0.257568359375
▁the 1.609375
▁study 6.78515625
▁describes 8.03125
▁the 0.865234375
▁apparent 9.0703125
▁link 6.33203125
▁between 0.5322265625
▁pain 6.2734375
▁and 0.7470703125
▁dem 8.3671875
oral 3.49609375
ization 0.281982421875
. 1.4599609375
▁Chron 6.23046875
ic 0.0287628173828125
▁pain 0.312255859375
▁is 1.30078125
▁always 6.3828125
▁accompanied 2.1875
▁by 0.05865478515625
▁negative 4.90234375
▁emot 1.482421875
ional 1.314453125
▁experiences 2.96875
▁and 2.12109375
▁blocks 11.046875
▁a 4.15234375
▁person 1.4033203125
’ 24.859375
s 1.9921875
▁ability 1.8544921875
▁to 0.047698974609375
▁receive 6.296875
▁joy 4.91796875
▁and 1.3935546875
▁satisfaction 3.03125
▁from 1.216796875
▁life 1.033203125
. 0.3251953125
▁The 1.890625
▁research 3.916015625
▁investig 5.296875
ates 0.46044921875
▁the 0.483154296875
▁development 5.9140625
▁of 0.1756591796875
▁de 3.84375
pression 0.254638671875
▁and 1.2861328125
▁anx 2.255859375
iety 0.004974365234375
▁among 2.369140625
▁patients 2.458984375
▁receiving 4.5
▁ph 6.625
arma 1.783203125
ce 0.00861358642578125
ut 0.00045871734619140625
ical 0.0106964111328125
▁op 5.04296875
io 0.1884765625
ids 0.6259765625
▁and 2.384765625
▁medical 6.171875
▁mar 1.498046875
iju 0.048919677734375
ana 0.00020039081573486328
▁( 4.390625
MM 0.68310546875
) 3.458984375
▁as 2.83984375
▁severe 9.921875
▁pain 1.6123046875
kill 3.076171875
ers 0.0019130706787109375
. 0.52880859375
▁It 3.236328125
▁comp 5.125
ares 0.052032470703125
▁the 0.630859375
▁effic 6.4140625
acy 0.00827789306640625
▁of 0.277099609375
▁pres 5.10546875
cri 1.7626953125
ptions 0.6845703125
▁and 2.298828125
▁exam 5.8203125
ines 0.01125335693359375
▁the 0.4482421875
▁possibility 3.796875
▁of 0.109375
▁post 7.203125
- 0.67333984375
tre 2.498046875
at 0.0246734619140625
ment 0.00739288330078125
▁de 1.8291015625
pression 0.10272216796875
. 1.7509765625
<0x0A> 2.30078125
There 4.9140625
▁is 1.0654296875
▁currently 4.5859375
▁a 1.1552734375
▁severe 4.91015625
▁lack 3.27734375
▁of 0.0261077880859375
▁information 2.103515625
▁about 1.4169921875
▁the 0.4765625
▁effects 2.91796875
▁of 0.0743408203125
▁op 1.8154296875
i 3.99609375
ates 0.11663818359375
. 3.830078125
▁They 4.8984375
▁manage 8.859375
▁pain 3.560546875
▁successfully 5.82421875
, 1.029296875
▁but 0.324462890625
▁the 2.630859375
▁past 9.5390625
▁few 2.517578125
▁dec 0.79052734375
ades 7.331371307373047e-05
▁indicated 9.671875
▁the 2.0390625
▁growing 4.6640625
▁concern 3.58203125
▁regarding 2.783203125
▁op 3.623046875
iate 0.689453125
▁ab 1.53515625
use 0.00832366943359375
▁in 3.4296875
▁forms 10.5234375
▁of 0.401611328125
▁over 3.30078125
d 0.350341796875
ose 0.1868896484375
▁and 0.69873046875
▁add 1.1181640625
iction 0.02740478515625
. 0.2044677734375
▁A 3.984375
▁more 5.7109375
▁manage 9.0
able 0.0037384033203125
▁and 2.244140625
▁sa 2.283203125
fer 7.963180541992188e-05
▁alternative 1.666015625
▁might 6.4140625
▁be 0.1898193359375
▁medical 2.681640625
▁mar 0.178466796875
iju 0.0036640167236328125
ana 0.0005488395690917969
. 1.5126953125
▁However 2.90625
, 0.00722503662109375
▁the 1.5947265625
▁legal 4.23828125
▁status 1.1962890625
▁and 2.75390625
▁novel 9.140625
ty 0.6630859375
▁of 0.210205078125
▁this 1.689453125
▁drug 2.091796875
▁do 5.02734375
▁not 0.0703125
▁allow 1.029296875
▁finding 8.7578125
▁a 2.337890625
▁large 4.3828125
▁number 1.4384765625
▁of 0.0037708282470703125
▁studies 1.3291015625
▁on 1.5361328125
▁its 0.98193359375
▁effect 2.060546875
iveness 0.437255859375
. 0.9619140625
▁Specifically 8.1953125
, 0.11529541015625
▁it 2.73046875
▁concerns 4.8359375
▁the 0.64697265625
▁emot 7.37109375
ional 0.01727294921875
▁condition 5.36328125
▁of 0.3837890625
▁patients 0.71875
▁experien 6.29296875
cing 3.445148468017578e-05
▁chron 1.1298828125
ic 0.0023956298828125
▁pain 0.0987548828125
. 0.65380859375
▁This 3.150390625
▁research 2.99609375
▁paper 6.21484375
▁a 2.185546875
ims 0.0004074573516845703
▁to 0.0924072265625
▁analyze 3.06640625
▁levels 9.6640625
▁of 0.0341796875
▁de 0.54736328125
pression 0.03619384765625
▁and 0.26953125
▁anx 0.042236328125
iety 0.0012140274047851562
▁among 0.798828125
▁people 3.26171875
▁receiving 0.94482421875
▁ther 8.0078125
apy 0.33935546875
▁by 5.26171875
▁comparing 7.94921875
▁the 0.9873046875
▁effects 2.169921875
▁of 0.0303192138671875
▁ph 2.455078125
arma 0.039642333984375
ce 0.0011568069458007812
ut 7.176399230957031e-05
ical 0.00390625
▁op 0.305419921875
io 0.162841796875
ids 0.058685302734375
▁and 0.275390625
▁MM 1.2138671875
. 1.0
<0x0A> 1.0068359375
The 1.3349609375
▁study 2.015625
▁was 2.06640625
▁conducted 0.7421875
▁in 1.529296875
▁the 1.4443359375
▁form 2.197265625
▁of 0.006374359130859375
▁collection 10.03125
▁and 1.6943359375
▁analysis 0.6806640625
▁of 0.04559326171875
▁statistical 4.203125
▁data 0.120361328125
. 0.89599609375
▁Part 4.94921875
icip 0.06683349609375
ants 0.04595947265625
▁were 0.70361328125
▁rec 3.2578125
ru 0.0010690689086914062
ited 4.839897155761719e-05
▁for 4.05078125
▁six 7.5546875
▁months 0.52197265625
▁at 3.771484375
▁two 2.498046875
▁major 5.4453125
▁pain 3.078125
▁relief 5.24609375
▁cent 1.5498046875
ers 0.07904052734375
▁in 0.70947265625
▁Israel 4.3203125
. 0.41552734375
▁The 1.1923828125
▁research 2.166015625
ers 1.505859375
▁used 2.705078125
▁The 8.0625
▁De 4.21484375
pression 0.01334381103515625
▁Module 10.1171875
▁of 0.95947265625
▁the 0.32568359375
▁Pat 2.287109375
ient 0.007503509521484375
▁Health 0.08447265625
▁Question 0.013946533203125
naire 0.0183258056640625
▁and 3.3515625
▁the 0.73095703125
▁General 1.6826171875
ized 0.69140625
▁An 0.016021728515625
x 0.0001443624496459961
iety 0.002651214599609375
▁Dis 0.5146484375
order 0.034881591796875
▁Sc 1.205078125
ale 0.068359375
▁to 1.7373046875
▁interview 7.06640625
▁participants 2.017578125
, 3.697265625
▁evaluate 5.56640625
▁their 0.7431640625
▁answers 6.48828125
, 0.853515625
▁and 0.1422119140625
▁behave 13.4140625
▁the 5.0390625
▁study 3.759765625
. 1.095703125
▁To 5.078125
▁specifically 9.7265625
▁evaluate 2.572265625
▁and 4.45703125
▁compare 1.158203125
▁the 0.36474609375
▁prob 11.0625
abilities 0.171875
▁of 0.1456298828125
▁de 0.86865234375
pression 0.04071044921875
▁or 4.55859375
▁anx 0.039794921875
iety 0.0004138946533203125
▁among 1.75
▁the 2.232421875
▁diverse 8.9609375
▁groups 1.513671875
, 1.369140625
▁the 1.05859375
▁study 2.736328125
▁used 1.5615234375
▁multiple 4.7109375
▁log 2.828125
istic 0.03564453125
▁regression 0.11273193359375
▁analysis 0.69775390625
▁and 2.513671875
▁chose 8.953125
▁medical 7.5390625
▁mar 0.360107421875
iju 0.0023822784423828125
ana 0.00034165382385253906
▁as 0.876953125
▁the 1.12890625
▁control 2.759765625
▁group 0.58984375
. 0.2822265625
<0x0A> 0.81591796875
This 3.4921875
▁type 6.1640625
▁of 0.0078277587890625
▁study 1.6826171875
▁is 1.2783203125
▁the 3.390625
▁most 1.91796875
▁reve 9.2265625
aling 0.0009212493896484375
▁and 1.0595703125
▁inclus 6.4375
ive 0.0027713775634765625
, 2.34375
▁as 1.9541015625
▁it 0.365966796875
▁contains 4.7421875
▁direct 6.34375
▁responses 4.9609375
▁from 0.8369140625
▁a 3.859375
▁large 0.93212890625
▁number 0.440673828125
▁of 0.003765106201171875
▁participants 1.4296875
. 0.6220703125
▁All 4.6953125
▁tools 9.09375
▁in 4.484375
▁the 0.6669921875
▁form 3.490234375
▁of 0.04620361328125
▁question 1.8017578125
na 0.040985107421875
ires 0.00011038780212402344
▁and 2.046875
▁scales 3.03515625
▁have 3.609375
▁already 4.52734375
▁been 0.18994140625
▁used 1.9072265625
▁and 2.08203125
▁proved 4.29296875
▁their 1.8115234375
▁effic 3.900390625
acy 8.463859558105469e-05
▁for 3.666015625
▁collect 4.6640625
ing 0.02044677734375
▁analyt 8.296875
ical 0.2440185546875
▁data 0.29248046875
. 0.412841796875
▁It 3.521484375
▁helps 4.75390625
▁to 0.95849609375
▁system 7.40234375
at 1.3388671875
ize 0.006732940673828125
▁and 1.58203125
▁class 4.0625
ify 0.0027637481689453125
▁distinct 9.25
▁kinds 6.26171875
▁of 0.0266571044921875
▁information 3.41015625
▁for 3.927734375
▁subsequent 4.1015625
▁un 8.015625
comp 5.34375
licated 0.06304931640625
▁services 11.6171875
. 0.591796875
▁Thus 4.49609375
, 0.024627685546875
▁research 4.4765625
ers 0.5693359375
▁can 1.35546875
▁compare 3.97265625
▁the 0.95849609375
▁effects 2.994140625
▁of 0.10791015625
▁medic 4.453125
ations 0.880859375
▁on 1.7958984375
▁patients 2.091796875
▁of 4.54296875
▁diverse 4.10546875
▁age 2.775390625
▁groups 0.72607421875
, 0.91943359375
▁background 5.0625
s 0.249755859375
, 0.07794189453125
▁physical 5.359375
▁conditions 1.423828125
, 0.09375
▁emot 5.5078125
ional 0.0655517578125
▁states 1.4169921875
, 0.11456298828125
▁and 0.445556640625
▁so 3.201171875
▁on 0.313232421875
. 0.0860595703125
<0x0A> 0.6533203125
The 1.1083984375
▁analysis 4.58203125
▁of 0.5703125
▁any 8.8203125
▁human 6.08203125
▁reaction 4.8515625
▁has 4.59375
▁a 1.7314453125
▁high 4.43359375
▁potential 3.4296875
▁of 1.6494140625
▁subject 6.125
iveness 3.87109375
▁and 1.3466796875
▁bias 2.27734375
, 1.9375
▁especially 2.39453125
▁regarding 4.40234375
▁people 4.4296875
▁in 3.9609375
▁severe 4.33203125
▁pain 0.3046875
▁and 2.642578125
▁un 5.31640625
stable 1.84375
▁emot 0.84375
ional 0.177490234375
▁condition 2.53515625
. 0.0704345703125
▁Perhaps 8.9140625
▁some 5.02734375
▁patients 2.34765625
▁tend 5.44921875
▁to 0.0204925537109375
▁ex 2.609375
agger 0.00164031982421875
ate 0.006378173828125
▁their 0.76123046875
▁de 5.1484375
press 1.390625
ive 0.2646484375
▁state 3.095703125
▁or 1.890625
▁vice 7.3671875
▁vers 0.0174407958984375
a 6.42538070678711e-05
, 1.01953125
▁de 7.2890625
- 4.98828125
emph 1.03515625
as 0.0063018798828125
ize 0.12200927734375
▁serious 6.5703125
▁difficulties 5.91015625
. 0.841796875
▁Because 6.18359375
▁the 2.2890625
▁survey 6.1328125
▁responses 6.76953125
▁were 1.6181640625
▁thoroughly 7.90625
▁anonymous 5.13671875
, 0.454345703125
▁the 1.4521484375
▁research 1.517578125
ers 0.30908203125
▁were 1.4892578125
▁unable 2.435546875
▁to 0.0036602020263671875
▁carefully 8.640625
▁analyze 1.6201171875
▁each 4.04296875
▁patient 2.54296875
’ 27.25
s 1.0224609375
▁reaction 3.658203125
▁and 2.404296875
▁compare 3.650390625
▁it 0.9208984375
▁to 1.25
▁the 0.765625
▁actual 5.7421875
▁states 7.25
▁of 0.74560546875
▁condition 7.28125
. 0.357177734375
▁More 6.87890625
▁accurate 3.771484375
▁answers 4.6484375
▁could 2.50390625
▁be 0.890625
▁obtained 1.021484375
▁by 1.3486328125
▁professional 7.40234375
▁psych 2.18359375
olog 0.317626953125
ists 0.0010671615600585938
▁via 7.98046875
▁personal 3.943359375
▁communication 4.6484375
▁and 1.8447265625
▁behavior 6.87109375
al 0.5390625
▁analysis 2.234375
. 0.23388671875
▁However 2.78515625
, 0.002719879150390625
▁this 1.943359375
▁method 2.84375
▁of 2.31640625
▁research 2.1171875
▁is 0.95654296875
▁way 7.8515625
▁more 1.6650390625
▁resource 6.54296875
- 0.4853515625
int 0.54052734375
ensive 0.00872039794921875
▁and 0.6279296875
▁energy 8.6484375
- 0.11419677734375
consum 0.312255859375
ing 0.00189208984375
. 0.5732421875
<0x0A> 0.6533203125
Part 5.453125
icip 0.07818603515625
ants 0.11444091796875
▁were 0.99755859375
▁rec 1.501953125
ru 0.0011873245239257812
ited 9.047985076904297e-05
▁for 1.1259765625
▁six 1.115234375
▁months 0.019866943359375
▁at 0.45361328125
▁two 0.1104736328125
▁major 0.365478515625
▁pain 0.036041259765625
▁relief 0.0300140380859375
▁cent 0.033294677734375
ers 0.00508880615234375
▁in 0.062469482421875
▁Israel 0.03472900390625
. 0.146484375
▁All 3.44140625
▁patients 1.546875
▁experienced 5.5390625
▁chron 1.91796875
ic 0.002349853515625
▁pain 0.09320068359375
▁for 3.5078125
▁at 0.74072265625
▁least 0.0010137557983398438
▁ 1.1025390625
3 1.4521484375
▁months 0.232666015625
. 1.02734375
▁The 1.462890625
▁study 1.8857421875
▁included 2.16015625
▁ 1.125
8 2.87109375
9 2.765625
0 3.5859375
▁participants 1.5234375
, 1.2421875
▁of 1.7822265625
▁which 0.41259765625
▁ 0.151611328125
4 1.6025390625
7 2.46875
4 2.755859375
▁( 2.189453125
5 0.089599609375
9 11.1796875
%) 1.029296875
▁were 0.476806640625
▁treated 4.6328125
▁sole 6.8671875
ly 0.00016438961029052734
▁with 0.489990234375
▁op 0.79443359375
io 0.396484375
ids 0.197265625
, 1.158203125
▁ 0.580078125
3 1.0693359375
2 2.07421875
9 2.544921875
▁( 0.043121337890625
4 1.1796875
1 1.2578125
%) 0.134033203125
▁were 1.3251953125
▁treated 0.5341796875
▁with 0.186279296875
▁MM 0.79248046875
, 0.263671875
▁and 0.162353515625
▁ 0.1414794921875
7 3.22265625
7 2.412109375
▁( 0.172607421875
8 3.791015625
. 1.1494140625
6 3.091796875
%) 0.055206298828125
▁acquired 9.703125
▁both 1.166015625
▁( 7.05078125
Fe 10.1171875
ing 2.75390625
old 0.0194244384765625
▁et 1.3935546875
▁al 0.0179901123046875
., 0.306396484375
▁ 0.00960540771484375
2 0.141357421875
0 0.00035834312438964844
1 0.371826171875
7 2.03125
). 0.1258544921875
▁The 1.349609375
▁remaining 6.94921875
▁ten 8.0859375
▁participants 1.39453125
▁who 5.65625
▁did 1.4931640625
▁not 0.00696563720703125
▁receive 1.8544921875
▁ph 3.078125
arma 0.060150146484375
ce 0.0014858245849609375
ut 1.990795135498047e-05
ical 0.0034084320068359375
▁op 1.01171875
io 0.078369140625
ids 0.0231781005859375
▁and 1.630859375
▁medical 2.291015625
▁mar 0.043426513671875
iju 0.00475311279296875
ana 8.535385131835938e-05
▁were 1.2822265625
▁with 6.05078125
dra 0.134521484375
wn 0.00012969970703125
▁from 0.2626953125
▁the 0.1131591796875
▁analysis 4.61328125
▁in 4.78125
▁the 1.169921875
▁research 4.25390625
. 0.568359375
▁Therefore 4.87890625
, 0.00787353515625
▁it 3.759765625
▁is 0.9384765625
▁not 2.7109375
▁possible 0.64794921875
▁to 0.0207672119140625
▁compreh 6.484375
ens 0.05718994140625
ively 0.0096588134765625
▁compare 1.951171875
▁patients 4.81640625
▁taking 4.3359375
▁medic 3.861328125
ations 0.47509765625
▁with 0.98974609375
▁those 1.181640625
▁who 1.125
▁do 1.7177734375
▁not 0.00838470458984375
. 0.7607421875
<0x0A> 0.65869140625
The 1.1025390625
▁study 1.6201171875
▁conducted 4.87109375
▁a 2.0625
▁correlation 6.15234375
▁type 7.31640625
▁of 0.45361328125
▁research 1.8798828125
▁with 2.841796875
▁variable 7.9375
▁measures 4.53515625
. 1.2451171875
▁It 2.14453125
▁evaluated 4.44921875
▁the 0.583984375
▁inter 6.28515625
dep 3.646484375
end 0.0005822181701660156
ence 0.01064300537109375
▁of 0.58740234375
▁various 3.896484375
▁factors 1.6337890625
▁that 2.79296875
▁affected 4.11328125
▁the 0.58203125
▁physical 6.875
▁and 0.96337890625
▁emot 0.47998046875
ional 0.0003724098205566406
▁condition 1.0029296875
▁of 0.1109619140625
▁patients 0.60400390625
▁experien 4.1953125
cing 2.5272369384765625e-05
▁chron 0.6025390625
ic 0.0004622936248779297
▁pain 0.0266265869140625
. 0.2154541015625
▁For 3.814453125
▁example 1.072265625
, 0.01503753662109375
▁the 1.20703125
▁survey 5.109375
▁showed 3.455078125
▁that 0.424072265625
▁the 1.71875
▁ratio 6.98828125
▁of 0.1236572265625
▁female 4.4453125
▁patients 0.78515625
▁was 1.849609375
▁remark 9.5078125
ably 0.0005183219909667969
▁higher 0.525390625
▁in 2.701171875
▁the 0.97705078125
▁op 4.6015625
i 4.11328125
ates 0.08233642578125
▁group 0.27587890625
▁compared 2.759765625
▁to 0.1214599609375
▁the 0.537109375
▁MM 0.489013671875
▁group 0.292724609375
. 0.472900390625
▁In 2.984375
▁turn 4.03125
, 0.002899169921875
▁people 5.9609375
▁on 5.51953125
▁op 1.392578125
i 0.445068359375
ates 0.00325775146484375
▁were 1.052734375
▁more 0.99853515625
▁likely 0.385009765625
▁to 0.060943603515625
▁report 3.15234375
▁major 5.98046875
▁de 0.388671875
press 1.2392578125
ive 0.00389862060546875
▁dis 0.51318359375
orders 1.3251953125
. 1.76171875
<0x0A> 2.421875
The 1.1162109375
▁question 5.70703125
na 1.3837890625
ires 7.927417755126953e-05
▁used 2.017578125
▁different 8.0390625
▁variable 8.734375
▁measures 0.81787109375
▁to 1.369140625
▁collect 2.23828125
▁information 1.9140625
. 1.6279296875
▁For 1.9609375
▁example 0.190673828125
, 0.00750732421875
▁it 4.0390625
▁included 2.533203125
▁compreh 8.65625
ensive 0.0281524658203125
▁so 6.875
cio 0.020904541015625
- 0.405029296875
dem 0.08282470703125
ographic 0.0386962890625
▁data 1.0107421875
: 4.859375
▁gender 1.5869140625
, 0.08990478515625
▁age 0.2020263671875
, 0.09027099609375
▁country 4.3515625
, 1.44921875
▁type 4.37890625
▁of 0.057647705078125
▁residence 3.85546875
▁( 3.50390625
urban 2.041015625
/ 2.96484375
r 0.06390380859375
ural 0.0004897117614746094
), 0.2362060546875
▁years 5.96875
▁of 0.1649169921875
▁education 0.673828125
, 0.1474609375
▁and 1.8427734375
▁employ 3.669921875
ment 0.004199981689453125
▁status 0.45849609375
. 0.1748046875
▁Pat 4.07421875
ients 0.09820556640625
▁were 1.1728515625
▁also 0.89208984375
▁asked 0.61669921875
▁about 1.13671875
▁their 0.62255859375
▁medical 2.732421875
▁history 0.40576171875
▁over 8.78125
▁the 0.1641845703125
▁years 3.958984375
▁and 1.806640625
▁the 1.8193359375
▁current 3.388671875
▁presence 5.79296875
▁of 0.054901123046875
▁any 2.68359375
▁severe 4.56640625
▁dise 1.46484375
ases 8.106231689453125e-05
▁such 4.19140625
▁as 0.00495147705078125
▁heart 2.42578125
▁failure 2.02734375
, 0.18408203125
▁di 1.8486328125
ab 0.0018177032470703125
etes 0.00431060791015625
, 0.124755859375
▁ar 3.791015625
th 0.1278076171875
rit 0.032073974609375
is 0.011962890625
, 0.04168701171875
▁and 1.5458984375
▁so 0.73388671875
▁on 0.0285491943359375
. 0.05078125
▁The 1.8876953125
▁third 7.18359375
▁measure 3.927734375
▁of 2.052734375
▁the 0.98291015625
▁question 2.990234375
naire 0.1507568359375
▁was 0.98046875
▁indicated 9.828125
▁by 0.61865234375
▁information 6.4453125
▁on 1.59375
▁any 5.35546875
▁twelve 13.6015625
- 1.1826171875
month 0.3662109375
▁and 5.7890625
▁lifetime 3.208984375
▁drug 4.67578125
▁and 3.458984375
▁alco 0.07843017578125
hol 8.499622344970703e-05
▁consumption 2.57421875
. 0.460693359375
▁In 3.484375
▁addition 0.80029296875
, 0.1268310546875
▁the 1.15625
▁record 7.78125
▁included 1.7587890625
▁a 2.505859375
▁pain 6.3984375
▁measurement 4.30078125
▁scale 1.0439453125
▁from 3.626953125
▁ 0.46533203125
0 0.42529296875
▁to 0.411376953125
▁ 0.006748199462890625
1 0.08453369140625
0 0.0723876953125
▁to 4.58984375
▁evaluate 1.5908203125
▁dis 5.9140625
com 0.210205078125
fort 0.0013151168823242188
▁feelings 7.37109375
▁during 3.30859375
▁the 0.90966796875
▁last 1.4560546875
▁month 1.5947265625
. 0.281982421875
<0x0A> 1.169921875
Am 6.9375
ong 0.0120697021484375
▁all 2.376953125
▁participants 1.970703125
▁in 3.517578125
▁the 0.16552734375
▁study 0.370361328125
, 0.05474853515625
▁ 0.6630859375
4 1.7666015625
2 2.712890625
. 1.8291015625
2 2.30078125
% 0.140625
▁suffered 4.80859375
▁from 0.1412353515625
▁de 1.736328125
pression 0.1578369140625
, 1.0595703125
▁and 1.759765625
▁ 0.1463623046875
3 1.708984375
7 2.23046875
% 2.75
▁experienced 2.3359375
▁excess 7.8203125
ive 0.09161376953125
▁anx 0.257568359375
iety 0.0014362335205078125
. 0.342529296875
▁The 1.4169921875
▁pl 11.171875
ur 1.0146484375
ality 0.00019156932830810547
▁of 0.1898193359375
▁de 3.5234375
press 1.2685546875
ive 0.0233306884765625
▁dis 1.7900390625
orders 0.060028076171875
▁among 3.763671875
▁patients 1.19140625
▁in 3.591796875
▁the 0.3662109375
▁op 1.458984375
i 0.9853515625
ates 0.004489898681640625
, 7.15234375
▁medical 2.951171875
▁mar 0.021942138671875
iju 0.0057525634765625
ana 3.2901763916015625e-05
, 0.12115478515625
▁and 0.06512451171875
▁mixed 6.1796875
▁OP 8.8515625
MM 5.84765625
▁groups 0.4609375
▁number 8.03125
ed 0.0118255615234375
▁ 0.12310791015625
5 2.193359375
7 2.48046875
. 0.2069091796875
1 2.369140625
%, 0.2479248046875
▁ 0.004383087158203125
2 3.021484375
2 2.431640625
. 0.10345458984375
3 2.232421875
%, 0.11688232421875
▁and 0.032318115234375
▁ 0.0028743743896484375
5 3.205078125
1 2.55859375
. 0.16943359375
4 2.14453125
%, 0.38818359375
▁respectively 0.0095672607421875
. 0.294677734375
▁The 1.4716796875
▁pl 4.51171875
ur 0.0220184326171875
ality 3.266334533691406e-05
▁of 0.040771484375
▁anx 0.92333984375
iety 0.010498046875
▁contained 10.984375
▁ 0.56787109375
4 1.57421875
8 2.380859375
. 0.06304931640625
4 2.30859375
% 0.50439453125
▁among 1.4521484375
▁OP 6.4609375
▁patients 9.0546875
, 0.269287109375
▁ 0.096923828125
2 1.49609375
1 2.4140625
. 0.13134765625
5 2.435546875
% 0.01122283935546875
▁among 0.427734375
▁MM 0.351806640625
▁patients 0.2476806640625
, 0.0116729736328125
▁and 0.0130462646484375
▁ 0.036529541015625
3 1.2392578125
8 2.640625
. 0.1605224609375
7 2.291015625
% 0.01322174072265625
▁among 0.235107421875
▁OP 4.0703125
MM 0.2186279296875
▁participants 3.63671875
. 0.2286376953125
▁Pat 5.82421875
ients 0.021697998046875
▁who 2.38671875
▁took 2.9453125
▁strong 8.1875
▁op 1.267578125
i 1.3984375
ates 0.003261566162109375
▁were 1.7451171875
▁t 8.90625
ended 1.248046875
▁to 0.013702392578125
▁place 10.34375
▁their 3.6328125
▁pain 2.671875
▁on 3.412109375
▁a 0.89599609375
▁scale 2.296875
▁of 0.63232421875
▁ 0.36083984375
9 2.81640625
▁to 1.375
▁ 0.0160675048828125
1 0.0233612060546875
0 0.09320068359375
▁( 2.564453125
Fe 1.5966796875
ing 0.007610321044921875
old 0.00041222572326660156
▁et 0.0291290283203125
▁al 0.0008025169372558594
., 0.006748199462890625
▁ 0.0014963150024414062
2 0.0005068778991699219
0 2.7298927307128906e-05
1 0.001739501953125
7 0.012176513671875
). 0.049346923828125
▁They 4.73046875
▁were 1.27734375
▁also 1.37109375
▁an 8.8203125
gu 4.58984375
ished 0.03515625
▁em 8.515625
otion 0.0104522705078125
ally 0.004241943359375
▁and 1.1181640625
▁react 6.765625
ed 0.06201171875
▁rad 9.5078125
ically 0.0027294158935546875
▁neg 5.359375
atively 0.001041412353515625
▁to 0.34619140625
▁almost 5.26171875
▁all 1.19921875
▁survey 8.3359375
▁questions 0.63720703125
. 0.2890625
▁Pat 4.1953125
ients 0.007648468017578125
▁who 1.140625
▁took 1.521484375
▁only 5.46484375
▁MM 0.88427734375
▁or 3.21875
▁mixed 3.376953125
▁medic 2.591796875
ations 0.336181640625
▁course 12.6640625
▁had 2.48046875
▁a 1.2744140625
▁significantly 2.548828125
▁more 4.078125
▁stable 3.443359375
▁emot 1.193359375
ional 0.00777435302734375
▁state 0.81982421875
▁and 1.4091796875
▁cop 5.61328125
ed 0.8095703125
▁with 0.7041015625
▁pain 1.44921875
▁more 1.6943359375
▁manage 6.94140625
able 2.32421875
. 0.52490234375
<0x0A> 0.70947265625
One 5.16796875
▁of 0.599609375
▁the 0.01739501953125
▁major 2.53515625
▁limitations 2.751953125
▁is 3.91796875
▁the 0.517578125
▁ins 4.78125
u 0.01873779296875
fficient 0.1253662109375
ly 4.7109375
▁high 2.9921875
▁response 2.974609375
▁rate 0.1207275390625
, 2.666015625
▁ 4.625
5 1.927734375
7 2.046875
% 2.12890625
▁instead 7.29296875
▁of 0.006458282470703125
▁ 0.6923828125
7 1.525390625
0 1.4580078125
% 1.1181640625
▁( 1.6220703125
Fe 0.245849609375
ing 0.0035648345947265625
old 0.00046539306640625
▁et 0.0062713623046875
▁al 0.0005483627319335938
., 0.00457000732421875
▁ 0.0011882781982421875
2 0.0003886222839355469
0 1.8835067749023438e-05
1 0.0008330345153808594
7 0.00597381591796875
). 0.03619384765625
▁It 2.67578125
▁can 3.2890625
▁be 0.425048828125
▁fairly 8.3359375
▁explained 1.4775390625
▁by 0.1678466796875
▁the 0.3291015625
▁weak 8.25
▁focus 7.1484375
▁of 0.46826171875
▁respond 6.2421875
ents 0.1302490234375
▁who 3.51953125
▁have 4.0
▁overcome 8.0625
▁severe 2.25390625
▁pain 0.4873046875
▁sens 8.6875
ations 1.140625
▁and 1.193359375
▁de 4.17578125
press 1.7568359375
ive 0.257080078125
▁episodes 3.9453125
. 0.5888671875
▁It 3.34375
▁is 0.8359375
▁not 2.638671875
▁clear 4.20703125
▁how 1.6787109375
▁to 3.525390625
▁use 5.36328125
▁these 3.0390625
▁statistics 3.380859375
, 2.546875
▁as 1.455078125
▁they 1.3759765625
▁still 6.109375
▁may 4.77734375
▁be 1.3173828125
▁relevant 5.2578125
▁for 1.408203125
▁the 1.833984375
▁overall 4.47265625
▁analysis 3.048828125
. 1.0546875
